Literature DB >> 12871299

Inherited platelet-based bleeding disorders.

M Cattaneo1.   

Abstract

Inherited platelet-based bleeding disorders include abnormalities of platelet number and function, and are generally classified based on the abnormal functions or responses. However, a clear distinction is problematic, and in this review, the classification has been based on abnormalities of platelet components that share common characteristics. Inherited thrombocytopenias are rare, but probably underdiagnosed. They are usually classified according to both platelet size and the presence or absence of clinical features other than those deriving from the platelet defect. Hereditary disorders of platelet function can be classified as resulting from: (i) abnormalities of the platelet receptors for adhesive proteins; (ii) abnormalities of the platelet receptors for soluble agonists; (iii) abnormalities of the platelet granules; (iv) abnormalities of the signal-transduction pathways; (v) abnormalities of the membrane phospholipids; and (vi) miscellaneous abnormalities of platelet function. The literature on these disorders is reviewed, and the underlying defects discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12871299     DOI: 10.1046/j.1538-7836.2003.00266.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

1.  Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome.

Authors:  Antonio Girolami; Silvia Vettore; Fabrizio Vianello; Giulia Berti de Marinis; Fabrizio Fabris
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

2.  Molecular defects of the platelet P2 receptors.

Authors:  Marco Cattaneo
Journal:  Purinergic Signal       Date:  2011-01-29       Impact factor: 3.765

3.  Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes.

Authors:  Alessandra Balduini; Christian Andrea Di Buduo; Alessandro Malara; Anna Lecchi; Paola Rebuzzini; Manuela Currao; Isabella Pallotta; Joseph A Jakubowski; Marco Cattaneo
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

4.  Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion.

Authors:  Shaojing Ye; Zubair A Karim; Rania Al Hawas; Jeffery E Pessin; Alexandra H Filipovich; Sidney W Whiteheart
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

5.  Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies.

Authors:  Gabriele Jedlitschky; Marco Cattaneo; Lena E Lubenow; Dieter Rosskopf; Anna Lecchi; Andrea Artoni; Giovanna Motta; Juliane Niessen; Heyo K Kroemer; Andreas Greinacher
Journal:  Am J Pathol       Date:  2010-02-04       Impact factor: 4.307

6.  Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.

Authors:  Ban B Dawood; Gillian C Lowe; Marie Lordkipanidzé; Danai Bem; Martina E Daly; Mike Makris; Andrew Mumford; Jonathan T Wilde; Steve P Watson
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

Review 7.  Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system.

Authors:  Kristina M Haley; Michael Recht; Owen J T McCarty
Journal:  Pediatr Res       Date:  2014-06-18       Impact factor: 3.756

8.  A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function.

Authors:  Nicole Soranzo; Augusto Rendon; Christian Gieger; Chris I Jones; Nicholas A Watkins; Stephan Menzel; Angela Döring; Jonathan Stephens; Holger Prokisch; Wendy Erber; Simon C Potter; Sarah L Bray; Philippa Burns; Jennifer Jolley; Mario Falchi; Brigitte Kühnel; Jeanette Erdmann; Heribert Schunkert; Nilesh J Samani; Thomas Illig; Stephen F Garner; Angela Rankin; Christa Meisinger; John R Bradley; Swee Lay Thein; Alison H Goodall; Tim D Spector; Panos Deloukas; Willem H Ouwehand
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

Review 9.  Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

Authors:  Natalie Mathews; Georges-Etienne Rivard; Arnaud Bonnefoy
Journal:  J Blood Med       Date:  2021-06-11

10.  Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.

Authors:  Reheman Adili; Madeline Jackson; Livia Stanger; Xiangrong Dai; Mandy Li; Benjamin Xiaoyi Li; Michael Holinstat
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.